ASH 2024 Insights: Upfront Use of Anti-CD38 Monoclonal Antibodies in NDMM Patients With Renal Failure - A Flatiron Real-World Analysis | VuMedi

Find latest Myeloma videos · 600+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: Upfront Use of Anti-CD38 Monoclonal Antibodies in NDMM Patients With Renal Failure - A Flatiron Real-World Analysis

By 2024 ASH Annual Meeting Insights Hub FEATURING Adeel Khan

By 2024 ASH Annual Meeting Insights Hub FEATURING Adeel Khan

74 views

February 28, 2025

Comments 0

Login to view comments. Click here to Login